Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

ClinicalTrials.gov ID: NCT01337089

Public ClinicalTrials.gov record NCT01337089. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 12:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Non-comparative, Open-label Extension Study to Assess the Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

Study identification

NCT ID
NCT01337089
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Jazz Pharmaceuticals
Industry
Enrollment
660 participants

Conditions and interventions

Interventions

  • Nabiximols Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 18, 2011
Primary completion
Jan 26, 2016
Completion
Jan 26, 2016
Last update posted
Apr 11, 2023

2011 – 2016

United States locations

U.S. sites
37
U.S. states
18
U.S. cities
34
Facility City State ZIP Site status
Not listed Phoenix Arizona 85018
Not listed Phoenix Arizona 85028
Not listed El Cajon California 92020
Not listed Gilroy California 95020
Not listed Glendale California 91204
Not listed Santa Rosa California 95403
Not listed Clearwater Florida 33756
Not listed Daytona Beach Florida 32117
Not listed Holiday Florida 34691
Not listed Jacksonville Florida 32257
Not listed Lynn Haven Florida 32444
Not listed Miami Florida 33136
Not listed Stuart Florida 34994
Not listed Tampa Florida 33609
Not listed Winter Park Florida 32789
Not listed Marietta Georgia 30060
Not listed Newnan Georgia 30265
Not listed Stockbridge Georgia 30281
Not listed Woodlawn Illinois 62898
Not listed Ashland Kentucky 41101
Not listed Bossier City Louisiana 71111
Not listed Shreveport Louisiana 71105
Not listed Saint Louis Park Minnesota 55426
Not listed Kansas City Missouri 64132
Not listed Missoula Montana 59802
Not listed Berlin New Jersey 08009
Not listed New York New York 10003
Not listed New York New York 10010
Not listed Flat Rock North Carolina 28731
Not listed Winston-Salem North Carolina 27103
Not listed Cleveland Ohio 44119
Not listed Philadelphia Pennsylvania 19146
Not listed Houston Texas 77089
Not listed Laredo Texas 78041
Not listed Salt Lake City Utah 84112
Not listed Salt Lake City Utah 84124
Not listed Lacey Washington 98503

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 91 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01337089, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 11, 2023 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01337089 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →